SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-029846
Filing Date
2020-06-19
Accepted
2020-06-19 06:05:49
Documents
113
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 20-F taro-20f_20200331.htm   iXBRL 20-F 5825317
2 EX-2.2 taro-ex22_301.htm EX-2.2 72764
3 EX-12.1 taro-ex121_7.htm EX-12.1 16988
4 EX-12.2 taro-ex122_6.htm EX-12.2 17372
5 EX-13 taro-ex13_8.htm EX-13 11062
  Complete submission text file 0001564590-20-029846.txt   18985676

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA taro-20200331.xsd EX-101.SCH 105363
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE taro-20200331_cal.xml EX-101.CAL 114769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE taro-20200331_def.xml EX-101.DEF 261314
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE taro-20200331_lab.xml EX-101.LAB 711882
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE taro-20200331_pre.xml EX-101.PRE 534774
23 EXTRACTED XBRL INSTANCE DOCUMENT taro-20f_20200331_htm.xml XML 4232654
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-35463 | Film No.: 20974231
SIC: 2834 Pharmaceutical Preparations